A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus.
Vial PA, Valdivieso F, Calvo M, Rioseco ML, Riquelme R, Araneda A, Tomicic V, Graf J, Paredes L, Florenzano M, Bidart T, Cuiza A, Marco C, Hjelle B, Ye C, Hanfelt-Goade D, Vial C, Rivera JC, Delgado I, Mertz GJ; Hantavirus Study Group in Chile.
Vial PA, et al. Among authors: ye c.
Antivir Ther. 2015;20(4):377-86. doi: 10.3851/IMP2875. Epub 2014 Oct 15.
Antivir Ther. 2015.
PMID: 25316807
Clinical Trial.